Equipment Qualification (DQ–PQ) & Calibration Management: FDA-Compliant Validation Practices 2026

Equipment Qualification (DQ–PQ) & Calibration Management: FDA-Compliant Validation Practices FDA-Compliant Equipment Qualification and Calibration Management for GMP Manufacturing 1. Introduction – Equipment as the Foundation of GMP In every FDA-regulated facility, equipment serves as the backbone of consistent product quality. Whether it’s a sterile filling line, bioreactor, or analytical balance, each unit must perform as intended — reproducibly, reliably, and traceably. The FDA mandates under 21 CFR 211.63 that “equipment shall be of appropriate design, adequate size, and suitably located for its intended use.” This expectation forms the cornerstone of the qualification lifecycle (DQ–IQ–OQ–PQ) and its ongoing calibration and maintenance…

Continue Reading... Equipment Qualification (DQ–PQ) & Calibration Management: FDA-Compliant Validation Practices 2026

Integrating CQAs and CPPs into equipment design qualification decisions

Integrating CQAs and CPPs into equipment design qualification decisions Integrating CQAs and CPPs into Equipment Design Qualification Decisions In the competitive landscape of pharmaceuticals, the significance of design qualification (DQ) for new equipment and systems cannot be overstated. The process encompasses the evaluation of critical quality attributes (CQAs) and critical process parameters (CPPs), crucial components in the development and manufacturing of safe and effective pharmaceutical products. This article serves as a comprehensive guide for regulatory affairs professionals, clinical operations, and quality assurance personnel tasked with ensuring compliance with FDA, EMA, and MHRA regulations. The integration of CQAs and CPPs into…

Continue Reading... Integrating CQAs and CPPs into equipment design qualification decisions

Case studies of poor DQ leading to costly redesign and qualification delays

Case Studies of Poor DQ Leading to Costly Redesign and Qualification Delays Case Studies of Poor DQ Leading to Costly Redesign and Qualification Delays Design Qualification (DQ) serves as a critical foundation in the regulatory landscape surrounding Good Manufacturing Practices (GMP) in the pharmaceutical and biopharmaceutical industries. With the increasing complexity of new GMP equipment design and systems accompanies a heightened focus on the robustness of design qualification processes. This article explores various case studies that demonstrate how inadequate or improper DQ can lead to costly redesigns and significant qualification delays, emphasizing the importance of thorough design review in compliance…

Continue Reading... Case studies of poor DQ leading to costly redesign and qualification delays

Regulatory expectations for design qualification in pharma and biotech plants

Regulatory Expectations for Design Qualification in Pharma and Biotech Plants Regulatory Expectations for Design Qualification in Pharma and Biotech Plants Design Qualification (DQ) is a critical component in ensuring that new equipment and systems within pharmaceutical and biotech plants meet regulatory expectations and operational requirements. Understanding the regulatory framework that governs DQ is essential for professionals in the fields of pharmaceutical production, clinical operations, and regulatory affairs. With a focus on compliance with the FDA, EMA, and MHRA guidelines, this article provides an in-depth look at the expectations and best practices surrounding DQ. Understanding Design Qualification (DQ) Design Qualification (DQ)…

Continue Reading... Regulatory expectations for design qualification in pharma and biotech plants

Linking URS, risk assessments and DQ activities for new equipment projects

Linking URS, Risk Assessments and DQ Activities for New Equipment Projects Linking URS, Risk Assessments and DQ Activities for New Equipment Projects The continuous evolution of pharmaceuticals necessitates stringent compliance with regulatory frameworks in the development and implementation of new equipment and systems. As such, ensuring a robust linkage between User Requirement Specifications (URS), risk assessments, and Design Qualification (DQ) activities is critical in meeting these compliance obligations. This article provides a comprehensive overview of the interrelations between URS, risk assessments, and DQ activities for new GMP equipment, focusing on best practices aligned with the FDA, EMA, and MHRA guidelines….

Continue Reading... Linking URS, risk assessments and DQ activities for new equipment projects

Design qualification checklist for FDA compliant facility and process equipment

Design Qualification Checklist for FDA Compliant Facility and Process Equipment Design Qualification Checklist for FDA Compliant Facility and Process Equipment In the pharmaceutical industry, ensuring compliance with regulatory standards is paramount. The design qualification (DQ) process is a critical component in the lifecycle of Good Manufacturing Practice (GMP) equipment and systems. This article provides a comprehensive guide on the design qualification checklist aimed at supporting professionals in achieving FDA compliance, alongside adherence to European Medicines Agency (EMA) and Medicines and Healthcare products Regulatory Agency (MHRA) regulations. Understanding Design Qualification: A Regulatory Perspective Design qualification (DQ) is a systematic approach that…

Continue Reading... Design qualification checklist for FDA compliant facility and process equipment

How to perform design qualification DQ for new GMP equipment and systems

How to perform design qualification DQ for new GMP equipment and systems How to Perform Design Qualification DQ for New GMP Equipment and Systems 1. Introduction to Design Qualification (DQ) Design Qualification (DQ) is a crucial phase in the equipment qualification process within Good Manufacturing Practice (GMP) frameworks. The DQ stage verifies that the proposed design of equipment or systems meets specified user requirements and regulatory standards. This phase is instrumental in ensuring that pharmaceutical production processes are reliable and compliant with regulatory guidelines set forth by the FDA, EMA, and MHRA. The DQ process is part of a larger…

Continue Reading... How to perform design qualification DQ for new GMP equipment and systems

Common DQ gaps identified in FDA and EU inspections and how to fix them

Common DQ gaps identified in FDA and EU inspections and how to fix them Common DQ gaps identified in FDA and EU inspections and how to fix them Design Qualification (DQ) plays a critical role in the lifecycle of pharmaceutical equipment and systems. As the first phase in the validation process, ensuring appropriate DQ contributes to effective Good Manufacturing Practice (GMP) compliance. Regulatory bodies such as the FDA in the United States and EMA in Europe rigorously assess DQ during inspections. This article outlines common DQ gaps identified in FDA and EU inspections and provides actionable solutions for pharmaceutical professionals…

Continue Reading... Common DQ gaps identified in FDA and EU inspections and how to fix them

Vendor collaboration and design review meetings to support robust DQ

Vendor Collaboration and Design Review Meetings to Support Robust DQ Vendor Collaboration and Design Review Meetings to Support Robust Design Qualification (DQ) In the highly regulated pharmaceutical sector, ensuring robust Design Qualification (DQ) is crucial for compliance, operational efficiency, and patient safety. The design qualification process establishes whether a proposed equipment or system design meets the defined requirements, particularly in the context of Good Manufacturing Practices (GMP) as outlined by the FDA and similar regulatory bodies such as the EMA and MHRA. This article provides a detailed exploration of vendor collaboration and design review meetings as foundational elements of the…

Continue Reading... Vendor collaboration and design review meetings to support robust DQ

DQ for single use, modular and skidded systems in modern GMP facilities

DQ for Single Use, Modular and Skidded Systems in Modern GMP Facilities Design Qualification (DQ) for Single Use, Modular and Skidded Systems in Modern GMP Facilities In the pharmaceutical industry, compliance with Good Manufacturing Practices (GMP) is paramount, especially when it comes to the qualification of equipment and systems. This article provides a comprehensive overview of design qualification (DQ) in the context of single use, modular, and skidded systems. It aims to provide valuable insights for professionals engaged in regulatory affairs, clinical operations, and quality assurance within the frameworks established by the FDA, EMA, and MHRA. Understanding Design Qualification (DQ)…

Continue Reading... DQ for single use, modular and skidded systems in modern GMP facilities